[go: up one dir, main page]

NO20081714L - Formuleringer med forbedret biotilgjenglighet omfattende et steroidderivat og et polyglykolysert glyserid - Google Patents

Formuleringer med forbedret biotilgjenglighet omfattende et steroidderivat og et polyglykolysert glyserid

Info

Publication number
NO20081714L
NO20081714L NO20081714A NO20081714A NO20081714L NO 20081714 L NO20081714 L NO 20081714L NO 20081714 A NO20081714 A NO 20081714A NO 20081714 A NO20081714 A NO 20081714A NO 20081714 L NO20081714 L NO 20081714L
Authority
NO
Norway
Prior art keywords
formulations
improved bioavailability
steroid derivative
polyglycolysed glyceride
polyglycolysed
Prior art date
Application number
NO20081714A
Other languages
English (en)
Inventor
Joseph Podolski
Original Assignee
Repros Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repros Therapeutics Inc filed Critical Repros Therapeutics Inc
Publication of NO20081714L publication Critical patent/NO20081714L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO20081714A 2005-09-29 2008-04-07 Formuleringer med forbedret biotilgjenglighet omfattende et steroidderivat og et polyglykolysert glyserid NO20081714L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72165305P 2005-09-29 2005-09-29
PCT/US2006/038637 WO2007038796A1 (en) 2005-09-29 2006-09-29 Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride

Publications (1)

Publication Number Publication Date
NO20081714L true NO20081714L (no) 2008-06-20

Family

ID=37602990

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081714A NO20081714L (no) 2005-09-29 2008-04-07 Formuleringer med forbedret biotilgjenglighet omfattende et steroidderivat og et polyglykolysert glyserid

Country Status (13)

Country Link
US (1) US20090149434A1 (no)
EP (1) EP1940413A1 (no)
JP (1) JP2009510127A (no)
KR (1) KR20080055956A (no)
CN (1) CN101316595A (no)
AU (1) AU2006294449A1 (no)
CA (1) CA2623678A1 (no)
CR (1) CR9944A (no)
EA (1) EA200800974A1 (no)
IL (1) IL190405A0 (no)
NO (1) NO20081714L (no)
WO (1) WO2007038796A1 (no)
ZA (1) ZA200803177B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
TW200831110A (en) * 2006-12-28 2008-08-01 Repros Therapeutics Inc Methods and formulations for improved bioavailability of antiprogestins
CN101784259B (zh) * 2007-08-21 2013-03-27 巴斯利尔药物股份公司 抗真菌组合物
US8299050B2 (en) * 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
TW200946541A (en) 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
TW200944537A (en) * 2008-04-03 2009-11-01 Idenix Pharmaceuticals Inc Formulations comprising a phosphoindole compound and one or more second active agents
AU2010237120B8 (en) * 2009-04-14 2015-11-26 Laboratoire Hra-Pharma Method for on-demand contraception
EP2545922A1 (en) 2011-07-12 2013-01-16 PregLem S.A. Treatment of excessive menstrual bleeding associated with uterine fibroids
EP2825159B1 (en) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
EP2854763B1 (en) * 2012-05-31 2018-09-26 Repros Therapeutics Inc. Formulations for vaginal delivery of antiprogestins
US20130338122A1 (en) * 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
CN104755087A (zh) 2012-11-02 2015-07-01 利普生物药剂公司 治疗孕酮依赖性病况的方法和组合物
HUE072591T2 (hu) 2013-07-19 2025-11-28 Boehringer Ingelheim Vetmedica Gmbh Tartósított, éterezett ciklodextrinszármazékokat tartalmazó folyékony, vizes gyógyászati készítmény
EA201992230A1 (ru) * 2013-12-04 2020-02-28 Бёрингер Ингельхайм Ветмедика Гмбх Улучшенные фармацевтические композиции пимобендана
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN109922811B (zh) * 2016-08-02 2023-09-19 度勒科特公司 包含至少一种氧化胆固醇硫酸酯以及聚亚烷基二醇、羧甲基纤维素和聚氧乙烯甘油酯中的至少一种的组合物及其使用方法
FR3113238B1 (fr) * 2020-08-05 2024-04-05 Gattefosse Sas Utilisation comme excipient, d’un melange de macrogolglyceride laurique et de polyethylene glycol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516268D0 (en) * 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
ATE194358T1 (de) * 1996-05-01 2000-07-15 Us Gov Health & Human Serv 21-substituierte progesteron derivate als antigestagene
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents

Also Published As

Publication number Publication date
CN101316595A (zh) 2008-12-03
KR20080055956A (ko) 2008-06-19
US20090149434A1 (en) 2009-06-11
ZA200803177B (en) 2009-03-25
WO2007038796A1 (en) 2007-04-05
CR9944A (es) 2008-10-03
JP2009510127A (ja) 2009-03-12
IL190405A0 (en) 2008-11-03
EA200800974A1 (ru) 2008-10-30
EP1940413A1 (en) 2008-07-09
CA2623678A1 (en) 2007-04-05
AU2006294449A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
NO20081714L (no) Formuleringer med forbedret biotilgjenglighet omfattende et steroidderivat og et polyglykolysert glyserid
MA29039B1 (fr) Dibenzylamines et derives
ZA200606734B (en) Thiazole derivative
PL1856057T3 (pl) Pochodne tetrahydroindolonu i tetrahydroindazolonu
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
DE502004007253D1 (de) Kalibriervorrichtung
NO20075628L (no) Farmasøytiske formuleringer
DE602007000856D1 (de) Weichkapseln mit palonosetron-hydrochlorid mit verbesserter stabilität und bioverfügbarkeit
DK1658848T3 (da) Formuleringer omfattende ecteinascidin og et disaccharid
EP1877075A4 (en) ANTIBODY TO MYOSTATIN
ATE553079T1 (de) Heteroarylphenylharnstoffderivat
ATE394399T1 (de) Tetrahydropyridoindolderivate
ATE540935T1 (de) Chinazolinderivate
DE602006007875D1 (de) Kapseln
DK1761541T3 (da) Pyrrazolo-pyrimidin-derivater
ATE417830T1 (de) Sulfonylbenzimidazolderivate
DK1732892T3 (da) Tetrahydrocarbazoler og derivater
ATE500227T1 (de) Amidderivate
EP1894930A4 (en) THIAZOLE DERIVATIVE
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
ZA200710105B (en) Thiazole derivatives and use thereof
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
DK1740574T3 (da) 4-amino-5-cyanopyrimidinderivater
DE602006003051D1 (de) Schlichtevorrichtung
TWI371272B (en) Substituted propanamide derivatives and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application